With presentations from Industry experts, including a keynote from Ken Getz, Professor of Tufts Center for the Study of Drug Development, RBQM Live is the virtual event of 2021 that you absolutely cannot afford to miss.

The Lineup

Ken Getz

[Professor, Tufts Center for the Study of Drug Development]

Lynne Cesario

[Global Risk-Based Monitoring Program Lead, Pfizer]

Sy Pretorius

[President, Clinical Development and Chief Medical Officer, Parexel]

Jacqueline Gough

[Jacqueline Gough, Director, Central Monitoring, Alexion Pharmaceuticals]

Esther Huffman O’Keefe

[Associate Director - Monitoring, Regeneron Pharmaceuticals]

Mary Arnould

[Director, Astellas Pharma]

Linda Sullivan

[Co-Founder & Executive Director, Metrics Champion Consortium]

Jonathan Rowe

[Head of R&D Quality & Risk Management, ZS Associates]

Lukasz Bojarski

[Head of Centralized Monitoring, AstraZeneca]

Nick May

[Risk-Based Monitoring Strategic Lead, Parexel]

Steve Young

[Chief Scientific Officer, CluePoints]

Ann Meeker O’Connell

[Ann Meeker O'Connell, VP, Integrated QMS/OMS, Vertex Pharmaceuticals]

Brett Wilson

[Senior Director, Data Monitoring and Management, Pfizer]

Stephanie Clark

[Director, Risk Management - Central Monitoring, Janssen]
Nicole Stansbury Headshot

Nicole Stansbury

[VP, Global Clinical Monitoring, Syneos Health]

Patrick Nadolny

[Global Head, Clinical Data Management, Sanofi ]

Dan Beaudry

[Senior Vice President, Customer Success, CluePoints]

Amy Kissam-Sands

[Vice President, Clinical Operations, Parexel]